The expansion covers the end-to-end clinical data lifecycle, moving beyond siloed AI tools to provide a unified data foundation. SiteroAI harmonizes inputs from EDC, central labs, and safety databases, allowing Ash to operate on a consistent, permission-aware view of trial information. According to CEO Sankesh Abbhi, the platform focuses on traceable records and accountable review rather than autonomous decision-making.

Ash for Study Configuration aims to cut setup times from months to weeks by generating structured drafts from protocols, while Ash for Data Management has demonstrated a 75% increase in speed during early deployments with a top-ten pharmaceutical company. The third workflow, Ash for Insights, provides continuous dashboarding for database lock forecasting and portfolio-wide risk visibility. All three modules maintain a strict governance model, requiring human sign-off at every decision gate to ensure compliance with clinical standards.